Recent advances in immunotherapy research have revealed crucial roles for new immune cells in combating cancer, leading to ...

Researchers are trying to get to the root of the problem in hopes of helping these patients who are suffering the longest.

A new injection, benralizumab, outperforms traditional steroids in treating asthma and COPD attacks, reducing treatment ...

A recent study in Nature Materials introduces an inhalable nanozyme treatment for viral pneumonia, showing promising results ...

Kinevant Sciences, a Roivant spinout designed to test an investigational monoclonal antibody, has reported that the asset ...

Jean C. Pfau, Ph.D. and Kinta Serve provide their perspective on asbestos, the pleural cavity, and autoimmune disease ...

Roivant said on Tuesday its drug did not meet the main goal in a mid-stage trial evaluating it in patients with a type of lung disease.

Severe COVID-19 has been considered an inflammatory "cytokine storm" condition in which the immune response to a viral infection becomes excessive, flooding the bloodstream and tissues with immune ...

As part of the COVID-19 International Research Team, researchers at the Johns Hopkins Kimmel Cancer Center, Children’s Hospital of Philadelphia, the University of Pittsburgh and Weill Cornell Medicine ...

The first new treatment for asthma attacks in 50 years is a drug already available—and it’s 4x more effective than steroid ...

I was diagnosed with COPD last year after struggling with multiple symptoms. I quit smoking over 10 years ago, but I'm ...

The study demonstrated that asthma treatment is safe, with no significant side effects compared to past studies of the drug.